Back to search
Smith-Magenis Syndrome (SMS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Smith-Magenis Syndrome (SMS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Smith-Magenis Syndrome (SMS) trials you may qualify forCurrently, there is no clinically available genetic-based treatment for RAI1 (Retinoic Acid-Induced 1) -related disorders other than symptomatic management and…
Autism Spectrum Disorders (ASD) are a neurodevelopmental disorder. Their prevalence is estimated at around 0.4% of the general population worldwide. Their early…
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient R…
This study will examine how a rare disease called Smith-Magenis syndrome (SMS) affects people and how they change over time. SMS is caused by a small chromosome…
The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosis…
The purpose of this study is to establish the efficacy and safety of Circadin in children with neurodevelopmental disorders and to determine the dose, this rand…